Skip to content

89bio, Inc.

CIK 0001785173

← back to feed
Revenue (TTM)
—
Q2 Jul 2025
Net Income (TTM)
−$379.82M
−158.2% YoY Q2 Jul 2025
EPS Diluted (TTM)
−$3.07
−75.5% YoY Q2 Jul 2025
Gross Margin
—
Q2 Jul 2025
Operating Margin
—
Q2 Jul 2025
Net Margin
—
Q2 Jul 2025
Free Cash Flow (TTM)
−$165.97M
Q2 Jul 2025
Cash
$129.08M
Q2 Jul 2025
Total Debt
$36.16M
Q2 Jul 2025
Shares Outstanding
148.31M sh
Q2 Jul 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings